Clinical trial / 2002
Ingestion of an Undaria pinnatifida preparation was associated with increased healing rates in active Herpetic infections
Fifteen patients with active and 6 with latent Herpetic infections (HSV-1, 2, EBV, Zoster) were monitored for their response to ingesting GFS, a preparation of Tasmanian Undaria pinnatifida, alongside in vitro tests. GFS ingestion was associated with increased healing rates in active infections, and patients with latent infection remained asymptomatic while ingesting it. In vitro, GFS extract inhibited Herpes viruses and showed mitogenic activity toward human T cells.
- Study type
- Clinical monitoring study with in vitro experiments
- Who was studied
- 21 patients with active (15 subjects) or latent (6 subjects) Herpetic infections
- What was measured
- Healing rates and symptom recurrence during active or latent Herpetic infection
THE PAPER
GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes.
Cooper R, Dragar C, Elliot K, Fitton JH, Godwin J, Thompson K. BMC Complement Altern Med, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.